Prostate cancer, Secondary cancers
Results
Phase 3
This is a summary of the results of the STAMPEDE trial that the team have published so far. The study included men who:
had a high risk of the cancer spreading or prostate cancer that has already spread to the or elsewhere in the body
were starting long term hormone therapy for the first time
were fit enough to have chemotherapy
Cancer Research UK supported this trial.
Recruitment start: 19 September 2005
Recruitment end: 31 March 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nick James
Cancer Research UK
Medical Research Council
Astellas
Clovis Oncology
Janssen
Novartis
Pfizer
Sanofi-Aventis
Last reviewed: 30 March 2023
CRUK internal database number: 16001
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
